- Home
- CAL vs SLDB Comparison
CAL vs SLDB Comparison
Compare CAL & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAL
- SLDB
- Stock Information
- Founded
- CAL 1878
- SLDB 2013
- Country
- CAL United States
- SLDB United States
- Employees
- CAL N/A
- SLDB N/A
- Industry
- CAL Shoe Manufacturing
- SLDB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CAL Consumer Discretionary
- SLDB Health Care
- Exchange
- CAL Nasdaq
- SLDB Nasdaq
- Market Cap
- CAL 503.2M
- SLDB 478.9M
- IPO Year
- CAL N/A
- SLDB 2018
- Fundamental
- Price
- CAL $13.38
- SLDB $6.39
- Analyst Decision
- CAL Hold
- SLDB Strong Buy
- Analyst Count
- CAL 1
- SLDB 10
- Target Price
- CAL $14.00
- SLDB $15.00
- AVG Volume (30 Days)
- CAL 809.7K
- SLDB 1.3M
- Earning Date
- CAL 09-04-2025
- SLDB 11-05-2025
- Dividend Yield
- CAL 2.06%
- SLDB N/A
- EPS Growth
- CAL N/A
- SLDB N/A
- EPS
- CAL 1.76
- SLDB N/A
- Revenue
- CAL $2,652,908,000.00
- SLDB N/A
- Revenue This Year
- CAL $1.74
- SLDB N/A
- Revenue Next Year
- CAL $5.85
- SLDB N/A
- P/E Ratio
- CAL $7.70
- SLDB N/A
- Revenue Growth
- CAL N/A
- SLDB N/A
- 52 Week Low
- CAL $12.09
- SLDB $2.41
- 52 Week High
- CAL $34.38
- SLDB $7.37
- Technical
- Relative Strength Index (RSI)
- CAL 42.58
- SLDB 58.02
- Support Level
- CAL $12.87
- SLDB $5.22
- Resistance Level
- CAL $14.41
- SLDB $6.79
- Average True Range (ATR)
- CAL 0.63
- SLDB 0.49
- MACD
- CAL -0.04
- SLDB 0.06
- Stochastic Oscillator
- CAL 26.50
- SLDB 72.16
About CAL Caleres Inc.
Caleres Inc is a footwear company that operates retail shoe stores and e-commerce websites, and designs, develops, sources, manufactures, and distributes footwear for people of all ages. The Company's business operations are organized into two reportable segments - famous Footwear and Brand Portfolio. The famous Footwear segment is comprised of its famous Footwear retail stores, famousfootwear.com, and famousfootwear.ca. The famous Footwear segment operated around 846 stores at the end of 2024. The Brand Portfolio segment offers retailers and consumers a cultivated portfolio of known brands. Geographically, the company generates the majority of its revenue from Domestic operations.
About SLDB Solid Biosciences Inc.
Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.